In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News


Using NLP Technology To Uncover Real-World Patient Insights

By Tiffany Druley

It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years.



Dr. Ali on the Need to Understand Real-World Disparities in BRCA Testing in TNBC

By Tiffany Druley

During the 2021 San Antonio Breast Cancer Symposium, findings from a real-world analysis evaluating racial disparities in BRCA testing for patients with TNBC were presented in a virtual poster. The results showed that the rate of BRCA testing was high overall in evaluated patients with TNBC, although a larger proportion of White patients received testing compared with Black or African American patients.



Achieving Comprehensive Patient Care Using Natural Language Processing

By Tiffany Druley

Telehealth has seen unprecedented growth within the past few years. As a result of this adoption, at the onset of the COVID-19 pandemic, health care organizations were quickly able to adapt their processes from being rooted in in-person care to relying on virtual care.


Load more

Press Releases


Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

By Chris Burkhardt

SAN FRANCISCO, NEW YORK, July 27, 2022 —Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $35 million growth funding transaction to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.



Syapse, Pierian Announce Genomics Collaboration to Power Precision Oncology

By Antoinette Cummins

SAN FRANCISCO, June 14, 2022 — Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse’s real-world evidence solutions designe…



Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022

By Antoinette Cummins

SAN FRANCISCO, May 27, 2022 – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on how the use of machine learning on real-world data can be used to power precision medicine solutions. Syapse will be presenting at th…


Load more



The path to revolutionized cancer care: Accessing data to rapidly generate patient insights to impact care

March 10, 2022

Cancer Care is being revolutionized with real-world data, which tells a comprehensive story for cancer patients. Oncology and technology leaders are always searching for creative approaches to reduce the complexity of exchanging data across multiple platforms. However, when making a sizable investment in getting access to the data you need to inform clinical decision-making, it’s essential to have an engine that can provide out–of–the–box capabilities and the flexibility to manage customizations. In this fireside chat, health-tech experts from Syapse and Infor will discuss the benefits of working in tandem to streamline oncology data acquisition to improve outcomes for cancer patients.

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.